Dr. Teals

Description

Dr. Teal's Pre & Post Workout Pain Relief Cream is presented in a 2 oz. (57 g) dosage form. The product is identified by the National Drug Code (NDC) 61012-010-57.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints. Specifically, it is effective for conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and older, a thin layer of the medication should be applied to the affected area no more than 3 to 4 times daily. It is essential to allow a minimum interval of 2 to 3 hours between applications to ensure optimal efficacy and minimize the risk of irritation.

For children under 12 years of age, it is recommended to consult a healthcare professional for appropriate dosing and administration guidance.

Contraindications

The product is contraindicated for use on wounds or damaged skin due to the potential for irritation and delayed healing. It should not be used in conjunction with a heating pad, as this may increase the risk of burns or skin damage. Additionally, the product is contraindicated in children under 12 years of age with arthritis-like conditions, as safety and efficacy have not been established in this population.

While using this product, it is essential to avoid contact with eyes or mucous membranes to prevent irritation. Furthermore, do not apply tight bandages, as this may restrict circulation and lead to adverse effects.

Warnings and Precautions

For external use only. It is imperative that healthcare professionals advise patients to avoid contact with the eyes or mucous membranes to prevent irritation or injury. Additionally, patients should be cautioned against applying tight bandages, as this may exacerbate skin reactions or impede proper healing.

In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Patients should be instructed to discontinue use and consult their healthcare provider if any of the following occur: the condition worsens or symptoms persist beyond 7 days, symptoms resolve only to recur within a few days, or if excessive skin irritation develops. These precautions are essential to ensure the safe and effective use of the product.

Side Effects

For external use only. Patients are advised to stop use and consult a doctor if the condition worsens or if symptoms persist for more than 7 days. Additionally, if symptoms clear up and then recur within a few days, or if excessive skin irritation occurs, medical advice should be sought.

Before using this product, patients should ask a doctor if they have redness over the affected area, as this may indicate a more serious condition that requires professional evaluation.

Drug Interactions

There are currently no specific drug interactions identified for the medication. Additionally, no interactions with laboratory tests have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time. It is advisable for healthcare professionals to remain vigilant and consult updated resources for any emerging data regarding potential interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Dr. Teals (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients with arthritis-like conditions under 12 years of age should not be treated with this medication. For children in this age group, it is advised to consult a healthcare professional before use.

Geriatric Use

There is no specific information regarding the use of Dr. Teal's Pre and Post Workout Pain Relief Cream in geriatric patients. Therefore, healthcare providers should exercise caution when recommending this product to elderly patients.

Given the lack of clinical data in this population, it is advisable to monitor geriatric patients closely for any adverse effects or unusual responses to the product. Additionally, healthcare providers may consider individual patient factors, such as comorbidities and concurrent medications, when determining the appropriateness of this cream for elderly patients.

As with all treatments, a thorough assessment of the patient's overall health status and potential risks is essential before use.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment. Regular monitoring of renal function may be warranted in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific details regarding overdosage for this medication (SPL code 34088-5), healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

Recommended Actions In the event of an overdose, it is essential to seek immediate medical attention. Healthcare providers should assess the patient's clinical status and consider the need for supportive care. Monitoring vital signs and providing symptomatic treatment may be necessary.

Potential Symptoms While specific symptoms of overdosage are not detailed, healthcare professionals should remain vigilant for any unusual or severe reactions that may arise following excessive intake of the medication. Symptoms may vary based on the pharmacological profile of the drug and the individual patient's response.

Management Procedures Management of an overdose should be tailored to the individual case. Healthcare professionals may consider the use of activated charcoal if the patient presents within a suitable timeframe and is not at risk of aspiration. Additionally, supportive measures, including intravenous fluids and monitoring of electrolytes, may be warranted based on the patient's condition.

In summary, due to the lack of specific overdosage information, healthcare professionals are encouraged to apply standard overdose management protocols and consult relevant toxicology resources as needed.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed not to use this product on wounds or damaged skin, and to avoid using it in conjunction with a heating pad. It is important to emphasize that this product should not be used on children under 12 years of age who have arthritis-like conditions.

Healthcare providers should counsel patients to stop using the product and consult a doctor if their condition worsens or if symptoms persist for more than 7 days. Additionally, patients should be advised to seek medical advice if symptoms resolve and then recur within a few days, or if they experience excessive skin irritation.

While using this product, patients should be cautioned to avoid contact with eyes or mucous membranes. They should also be instructed not to bandage the area tightly. Finally, healthcare providers should recommend that patients consult a doctor before use if there is redness over the affected area.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within the temperature range of 20° to 25°C (68° to 77°F) to maintain its efficacy and stability. Proper storage conditions should be observed to ensure the integrity of the product throughout its shelf life.

Additional Clinical Information

The medication is administered topically. For adults and children aged 12 years and older, a thin layer should be applied to the affected area no more than 3 to 4 times daily, with a minimum interval of 2-3 hours between applications. For children under 12 years of age, it is advised to consult a doctor before use.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Dr. Teals, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)